Table 1.
DEMOGRAPHICS and COMORBIDITIES in Transfused Versus Non-Transfused Cohorts
| Control (n=18124) | Transfusion (n=305) | P-Value | |||
|---|---|---|---|---|---|
| 18124 | 305 | ||||
| DEMOGRAPHICS | |||||
| Age (Mean ± SD)a | 68.84 ± 9.415 | 72.53 ± 9.937 | <0.001 | ||
| Age (years) | <0.001 | ||||
| x ≤ 55 | 1513 | 8.35% | 15 | 4.92% | |
| 55 < x ≤ 65 | 4606 | 25.41% | 49 | 16.07% | |
| 65 < x ≤ 75 | 7401 | 40.84% | 108 | 35.41% | |
| 75 < x ≤ 85 | 4218 | 23.27% | 111 | 36.39% | |
| 85 < x | 386 | 2.13% | 22 | 7.21% | |
| Sex | <0.001 | ||||
| Female | 9626 | 53.11% | 223 | 73.11% | |
| Male | 8498 | 46.89% | 82 | 26.89% | |
| Race/Ethnicity | 0.838 | ||||
| American Indian Alaska Native | or 70 | 0.39% | 0 | 0.00% | |
| Asian or Pacific Islander | 115 | 0.63% | 3 | 0.98% | |
| Black or African American | 842 | 4.65% | 16 | 5.25% | |
| Hispanic | 4 | 0.02% | 0 | 0.00% | |
| White or Caucasian | 15431 | 85.14% | 259 | 84.92% | |
| Other | 1662 | 9.17% | 27 | 8.85% | |
| Body Mass Index (kg/m2) | <0.001 | ||||
| Normal | 2856 | 15.76% | 75 | 24.59% | |
| Overweight | 5881 | 32.45% | 104 | 34.10% | |
| Class I Obese | 4848 | 26.75% | 70 | 22.95% | |
| Class II Obese | 2622 | 14.47% | 29 | 9.51% | |
| Class III Obese | 1917 | 10.58% | 27 | 8.85% | |
| PRE-OPERATIVE COMORBIDITIES | |||||
| Diabetes Mellitus | <0.001 | ||||
| No Diabetes Mellitus | 15157 | 83.63% | 232 | 76.07% | |
| Non-Insulin Dependent | 2168 | 11.96% | 46 | 15.08% | |
| Insulin Dependent | 799 | 4.41% | 27 | 8.85% | |
| Smoking History | 1803 | 9.95% | 30 | 9.84% | 0.948 |
| Dyspnea | 0.015 | ||||
| No Dyspnea | 16924 | 93.38% | 274 | 89.84% | |
| Moderate Exertion | 1143 | 6.31% | 28 | 9.18% | |
| At Rest | 57 | 0.31% | 3 | 0.98% | |
| Ventilator Dependence | 0 | 0.00% | 0 | 0.00% | - |
| COPD | 1103 | 6.09% | 34 | 11.15% | <0.001 |
| Ascites | 0 | 0.00% | 1 | 0.33% | 0.017 |
| Congestive Heart Failure | 74 | 0.41% | 4 | 1.31% | 0.040 |
| Hypertension | 12095 | 66.73% | 225 | 73.77% | 0.010 |
| Acute Renal Failure | 7 | 0.04% | 2 | 0.66% | 0.009 |
| Dialysis | 50 | 0.28% | 6 | 1.97% | <0.001 |
| Disseminated Cancer | 26 | 0.14% | 4 | 1.31% | 0.001 |
| Open Wounds/Wound Infections | 58 | 0.32% | 3 | 0.98% | 0.080 |
| Chronic Steroid Use | 779 | 4.30% | 16 | 5.25% | 0.419 |
| Weight Loss | 25 | 0.14% | 1 | 0.33% | 0.352 |
| Bleeding Disorders | 432 | 2.38% | 20 | 6.56% | <0.001 |
| Transfusions (within 72 hours preop) | 14 | 0.08% | 3 | 0.98% | 0.003 |
| Systemic Sepsis | 45 | 0.25% | 2 | 0.66% | 0.222 |
| Functional Status | <0.001 | ||||
| Independent | 17678 | 97.54% | 283 | 92.79% | |
| Partially Dependent | 314 | 1.73% | 18 | 5.90% | |
| Totally Dependent | 15 | 0.08% | 2 | 0.66% | |
aValues expressed as Mean ± Standard Deviation (SD) All other values expressed as (%) and N COPD: Chronic obstructive pulmonary disease